ReviewFrontiers in pharmacology2023

LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials.

Beatrice Noce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.